Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 22, 20 December 2023
* Author to whom correspondence should be addressed.
The prevalence rates of Type 2 Diabetes Mellitus (T2DM) continue to rise globally making it an urgent health concern warranting comprehensive examination closely scrutinizing pathophysiology causes symptoms management techniques as well as anticipated methods addressing how best to prevent or cure resulting complications. We know that T2DM is characterized by defective insulin secretion and tissues not responding adequately to treatment- a condition exclusively termed Insulin Resistance - which could influence both genetic predisposition or environmental factors like obesity or sedentary lifestyles. Increased morbidity indicators ranging from myocardial infarction peripheral vascular disease and stroke alike make timely diagnosis imperative. Lifestyle modifications offer optimal intervention possibilities for both preventing onset or long-standing concerns. A concentration on bolstering insulin sensitivity while halting progressive pancreatic β cell failure that common among T2DM patients is to enhance comprehensive and effective treatment plans. From the diversity of T2DM established in terms of its symptoms points to the need for targeted preventive procedures designed towards reducing cases in the future.
type 2 diabetes mellitus, insulin resistance, genetic predisposition, prevention strategies, treatment options
1. International Diabetes Federation. IDF Diabetes Atlas 6th Edition. IDF [online], (2013) http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf .
2. DeFronzo, Ralph A. "Pathogenesis of type 2 diabetes mellitus." Medical clinics 88.4: 787-835 (2004).
3. DeFronzo, Ralph A., et al. "Type 2 diabetes mellitus." Nature reviews Disease primers 1.1: 1-22(2015).
4. Galicia-Garcia, Unai, et al. "Pathophysiology of type 2 diabetes mellitus." International journal of molecular sciences 21.17: 6275 (2020).
5. Kahn, Steven E., Mark E. Cooper, and Stefano Del Prato. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet 383.9922: 1068-1083 (2014).
6. Lebovitz, Harold E. Type 2 diabetes: an overview. Clinical chemistry 45.8: 1339-1345 (1999).
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).